Abstract Importance: Effective therapeutics for Alzheimer’s disease and mild cognitive impairment are needed. Objective: To determine whether a precision medicine approach to Alzheimer’s disease and mild cognitive impairment, in which potential contributors to cognitive decline are identified and targeted therapeutically, is effective enough in a proof-of-concept trial to warrant a larger… [Read More]
Precision Medicine Approach to Alzheimer’s Disease: Successful Proof-of-Concept Trial
by admin | May 25, 2021 | White Paper

